- < About Recipharm
Recipharm is one of Europe’s leading pharmaceutical Contract Development and Manufacturing Organisations (CDMO).
Recipharm’s Manufacturing Services supply several hundred different products in a variety of dosage forms including solid dose, semi solids, steriles (liquids and freeze dried), beta-lactams, hormones, dry powder metered dose inhalers, oral liquids and granulates, from our facilities across Europe.
Recipharm’s Pharmaceutical Development Services group offer services from straight forward clinical supply through to more complex product development and formulation. From our pharmaceutical development centre we can work on a variety of technologies, including sterile products. Formulation development, clinical supplies, analytical development, stability studies, packaging development and raw material selection are all core activities.
The company is privately owned and extremely robust financially. We have grown both organically and through acquisition since our inception in 1995. Both of our owners, Lars Backsell (Chairman) and Thomas Eldered (CEO) are actively involved in the day to day business which ensures that we can make decisions quickly and efficiently. We are extremely proud of our environmental record and the working processes we adopt seek to minimise the impact our operations have on the world.
We now employ around 1600 people with a sales turnover in excess of SEK 2.1 bn and we continue to invest heavily in our facilities and processes. Throughout our history we have always stayed true to our key values and as a result are able to attract and retain the finest talent. You can be confident when working with Recipharm that we will deliver the best possible results.